ArticleJournal of conservative dentistry and endodontics2025
Comparative evaluation of various direct pulp capping materials using different blood derivatives on disease-free tooth: A histopathological assessment case series.
Article in Journal of conservative dentistry and endodontics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This histopathological case series evaluates the efficacy of advanced direct pulp capping (DPC) materials, including advanced platelet-rich fibrin (A-PRF+), light cured calcium hydroxide (Cal LC), and mineral trioxide aggregate (MTA) powder and putty, in preserving pulp vitality. The study utilized sound premolars to assess dentinal bridge formation and pulp healing. Histological findings revealed significant differences in dentinal bridge width among the tested materials. A-PRF+ demonstrated expedited healing outcomes, with MTA putty outperforming MTA powder in stabilizing A-PRF+. Cal LC showed limited therapeutic efficacy. The study suggests that combining blood derivatives with easy-setting materials may offer a promising solution for DPC, preserving tooth vitality. Further research is warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.